2019 -
2023 Strategic Advisor for Aeterna Zentaris @
2000 -
2017 Board member of the German pharmaceutical (BPI) and industrial chemical association (VCI) Hesse and GER @
2008 -
2017 Member Advising Counsel @
2016 -
now Chairman board of directors Cell BT Inc. @ Cell BT Inc.
2013 -
now Strategic Advisor to Ergomed PLC and UK @
2014 -
2022 Advisor to Oncoscience AG and GmbH @ Oncoscience AG/GmbH
2014 -
2017 Chairman Supervisory Board of Oncoscience AG and thereafter member of the Supervisory Board until 2017 @
2016 -
2017 Consultant to River Rock and Immodulon and UK @ Immodulon Therapeutics Limited
2010 -
2016 Chairman Advisory Board @ ElexoPharm
Juergen Engel Education
Technische Universität Carolo-Wilhelmina zu Braunschweig
Dr. rer. nat., Dr. rer. nat. habil (Chemistry, Pharmaceutical Science)
Juergen Engel Summary
Juergen Engel, based in Germany, is currently a Chief Executive Officer at Toleris Biotherapeutics. Juergen Engel brings experience from previous roles at AEterna Zentaris Inc., Verband der Chemischen Industrie e.V. (VCI), GIG and Cell BT Inc.. Juergen Engel holds a Dr. rer. nat., Dr. rer. nat. habil in Chemistry, Pharmaceutical Science @ Technische Universität Carolo-Wilhelmina zu Braunschweig. Juergen Engel has 1 emails on RocketReach.
Get contact details of over 700M profiles across 60M companies - all with industry-leading accuracy. Sales and Recruiter users, try out our Email Finder Extension.
Use our AI-Powered Email Finder
Find business and personal emails and mobile phone numbers with exclusive coverage across niche job titles, industries, and more for unparalleled targeting. Also available via our Contact Data API.